Public Profile

Guangji Pharmaceutical

Guangji Pharmaceutical Co., Ltd., commonly referred to as Guangji Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in the early 2000s, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern therapeutics. With a strong operational presence across various regions in China, Guangji Pharma focuses on innovative drug formulations and health supplements that cater to diverse medical needs. Their core offerings include herbal extracts and prescription medications, distinguished by their commitment to quality and efficacy. Recognised for its robust research and development capabilities, Guangji Pharmaceutical has achieved notable milestones, positioning itself as a trusted name in the healthcare sector. The company continues to expand its market reach, driven by a dedication to improving patient outcomes and advancing healthcare solutions.

DitchCarbon Score

How does Guangji Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Guangji Pharmaceutical's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Guangji Pharmaceutical's reported carbon emissions

Guangji Pharmaceutical, headquartered in CN, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies in this sector are often encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As Guangji Pharmaceutical navigates its sustainability journey, it may consider aligning with industry standards to enhance its climate commitments and transparency.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Guangji Pharmaceutical's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Guangji Pharmaceutical is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Guangji Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Sword Health

PT
Health Services
Updated 11 days ago

Glaukos

US
Health Services
Updated 10 days ago

jrs

DE
Health Services
Updated 11 days ago

Gracure Pharmaceuticals Ltd.

IN
Health Services
Updated 11 days ago

Xebios

DE
Health Services
Updated 11 days ago

Little Brothers Bakery

US
Health Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers